Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lupin LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500257NSE Symbol: LUPINP/E(TTM):17.69
ISIN Demat:INE326A01037Div & Yield %:0.59EPS(TTM):115.47
Book Value(Rs):531.5387173Market Cap ( Cr.):93301.24Face Value(Rs):2
    Change Company 
Date Headline
13-Sep-25 Lupin receives ESG rating of 59
11-Sep-25 Lupin Ltd spurts 0.51%, gains for fifth straight session
11-Sep-25 Lupin Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Sep-25 Lupin Ltd - Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates
11-Sep-25 Lupin Ltd - Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates
08-Sep-25 Lupin Ltd - Lupin Limited - Updates
06-Sep-25 Lupin's Aurangabad unit completes product-specific pre-approval USFDA inspection
06-Sep-25 Lupin's Aurangabad-based facility gets two observations from US FDA
06-Sep-25 Lupin Ltd - U.S. FDA Has Conducted A Product-Specific Pre-Approval Inspection At The CompanyS Chhatrapati Sambhajinagar ..
03-Sep-25 Lupin receives USFDA approval for Risperidone for extended-release injectable suspension
<< < 1 2 3 4   > >>